Preprint Review Version 1 This version is not peer-reviewed

Identifying Tools That Assess Factors That May Lead to Adverse Effects in Australian Aged-Care Facilities: A Scoping Review

Version 1 : Received: 26 February 2020 / Approved: 29 February 2020 / Online: 29 February 2020 (03:41:22 CET)

A peer-reviewed article of this Preprint also exists.

Qasim, H.; Simpson, M.; Guisard, Y.; de Courten, B. A Comprehensive Evaluation of Studies on the Adverse Effects of Medications in Australian Aged care Facilities: A Scoping Review. Pharmacy 2020, 8, 56. Qasim, H.; Simpson, M.; Guisard, Y.; de Courten, B. A Comprehensive Evaluation of Studies on the Adverse Effects of Medications in Australian Aged care Facilities: A Scoping Review. Pharmacy 2020, 8, 56.

Journal reference: Pharmacy 2020, 8, 56
DOI: 10.3390/pharmacy8020056

Abstract

Aim: this scoping review was designed to identify studies that assess the adverse drug reactions (ADRs) for older people in Australian aged-care facilities. This review critically evaluated each published study to identify the risk of, or actual adverse drug events in older people. Inclusion criteria: This review considered any clinical studies that examined the adverse effects of medications in older people who were living in aged-care facilities. This review considered qualitative studies, analytical studies, RCTs, descriptive cross-sectional studies, and analytic observational studies that explored the use of medications and their adverse effects on older people in clinical settings (including aged care facilities). Methods: An initial search of the PubMed, OvidSP, EBSCOHost, MEDLINE, ScienceDirect, Wiley Online, SAGE, and SCOPUS databases, with full text was performed, followed by an analysis of the article’s title and abstract. Additionally, MeSH was used to describe the article. The initial round of the database search was based on inclusion criteria from studies that assessed tools or protocols aiming to identify the adverse effects of medications on the elderly population suffering chronic conditions or multiple co-morbidities. Two reviewers screened the retrieved papers for inclusion. The data presented in this review are in tabular forms and a narrative summary which aligns with the review’s objectives. Results: Seven studies were identified, and the extracted data from these studies were grouped according their characteristics and the auditing results of each study. Conclusion: There was no comprehensive or broadly adverse drug reaction assessment tool derived from Australian data that has been used on the elderly in an Australian healthcare setting.

Subject Areas

systematic review; ADR assessment; elderly; aged-care facilities; medications monitoring; nursing home; drug review

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.